JOP20200323A1 - طرق لتصنيع تركيبات الأحماض الأمينية - Google Patents

طرق لتصنيع تركيبات الأحماض الأمينية

Info

Publication number
JOP20200323A1
JOP20200323A1 JOP/2020/0323A JOP20200323A JOP20200323A1 JO P20200323 A1 JOP20200323 A1 JO P20200323A1 JO P20200323 A JOP20200323 A JO P20200323A JO P20200323 A1 JOP20200323 A1 JO P20200323A1
Authority
JO
Jordan
Prior art keywords
methods
amino acid
acid compositions
manufacturing amino
manufacturing
Prior art date
Application number
JOP/2020/0323A
Other languages
English (en)
Inventor
Andrew M Wood
Thomas Hanlon
Ralph Yamamoto
Daniel Rothenberg
Denise K Kwok
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of JOP20200323A1 publication Critical patent/JOP20200323A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Abstract

يوفر الكشف الحالي طرق لتصنيع مستحضرات ممزوجة واسعة النطاق تشتمل على واحد أو أكثر من الأحماض الأمينية حيث يكون للمستحضرات خواص معينة.
JOP/2020/0323A 2018-06-20 2019-12-20 طرق لتصنيع تركيبات الأحماض الأمينية JOP20200323A1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862687725P 2018-06-20 2018-06-20

Publications (1)

Publication Number Publication Date
JOP20200323A1 true JOP20200323A1 (ar) 2020-12-14

Family

ID=67226342

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2020/0323A JOP20200323A1 (ar) 2018-06-20 2019-12-20 طرق لتصنيع تركيبات الأحماض الأمينية

Country Status (17)

Country Link
US (1) US11679089B2 (ar)
EP (1) EP3810168A1 (ar)
JP (1) JP2021529735A (ar)
KR (1) KR20210023846A (ar)
CN (1) CN112823018A (ar)
AR (1) AR115581A1 (ar)
AU (1) AU2019288371A1 (ar)
BR (1) BR112020025831A2 (ar)
CA (1) CA3099762A1 (ar)
CL (1) CL2020003277A1 (ar)
IL (1) IL279328A (ar)
JO (1) JOP20200323A1 (ar)
MA (1) MA52957A (ar)
MX (1) MX2020013732A (ar)
SG (1) SG11202011611XA (ar)
TW (1) TW202015668A (ar)
WO (1) WO2019246201A1 (ar)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN110678172A (zh) 2017-04-28 2020-01-10 胺细拉健康公司 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
EP3810168A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Methods of manufacturing amino acid compositions
TW202315605A (zh) 2021-07-26 2023-04-16 美商胺細拉健康公司 用於治療ｃｏｖｉｄ—１９急性後期後遺症的胺基酸組合物及方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
WO1994014458A1 (en) 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
DE04759123T1 (de) * 2003-04-07 2005-08-18 Novetide Ltd. Verfahren zur herstellung cyclischer peptide
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
EP1699458A4 (en) 2003-12-30 2012-04-25 Reddys Lab Ltd Dr PHARMACEUTICAL COMPOSITION
US20060073254A1 (en) 2004-10-04 2006-04-06 Steve Catani No-carb tabletop sweeteners substitute
WO2006062238A1 (ja) 2004-12-07 2006-06-15 Ajinomoto Co., Inc. アミノ酸の微粉末及びその懸濁液
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
WO2011043647A1 (en) * 2009-10-09 2011-04-14 N.V. Nutricia Amino acid composition with improved dispersibility
JP2012136492A (ja) 2010-12-25 2012-07-19 Shiga Prefecture Seiyaku Kk 服用感を改善された漢方内服液剤
WO2015002527A1 (en) * 2013-07-05 2015-01-08 N.V. Nutricia Amino acid composition for use in the treatment of a pdd
EP3738590A1 (en) 2013-07-31 2020-11-18 Leeds Beckett University Dietary supplement comprising amino acids for the treatment of sarcopenia
JP2016537402A (ja) 2013-09-25 2016-12-01 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 癌の処置における、腫瘍形成、癌細胞の増殖および浸潤の予防および低減のための組成物および配合物、ならびにその生成方法および使用方法
US20180125926A1 (en) 2013-09-25 2018-05-10 Axcella Health Inc. Compositions and Formulations and Methods of Production and Use Thereof
FR3032883B1 (fr) 2015-02-24 2017-03-17 International Nutrition Res Company Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
JO3543B1 (ar) * 2015-09-28 2020-07-05 Applied Pharma Res تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم
ES2878580T3 (es) * 2016-02-04 2021-11-19 Czap Res And Development Llc Vehículos de complejos de inclusión de ciclodextrina estratificados y de liberación controlada
PL238958B1 (pl) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
US20180015122A1 (en) * 2016-07-14 2018-01-18 Companion Supplements, LLC Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20190147A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
JP2018154598A (ja) 2017-03-21 2018-10-04 株式会社明治 アミノ酸含有顆粒およびその製造方法
CN110678172A (zh) 2017-04-28 2020-01-10 胺细拉健康公司 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法
CN111295187A (zh) 2017-08-14 2020-06-16 胺细拉健康公司 用于治疗肝脏疾病的氨基酸组合物
KR20200040276A (ko) 2017-08-14 2020-04-17 악셀라 헬스 인크. 신경 손상 치료를 위한 아미노산 조성물
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
US20210275479A1 (en) 2018-06-20 2021-09-09 Axcella Health Inc. Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditions
EP3810272A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the reduction or treatment of fibrosis
CN112839712A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于减少或治疗发炎的组合物和方法
AR115585A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo
AR115583A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Composiciones y métodos para el tratamiento de las enfermedades y trastornos del hígado
EP3810168A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Methods of manufacturing amino acid compositions
BR112020025702A2 (pt) 2018-06-20 2021-03-16 Axcella Health Inc. Composições para terapia e saúde contendo aminoácidos com gosto amargo

Also Published As

Publication number Publication date
EP3810168A1 (en) 2021-04-28
TW202015668A (zh) 2020-05-01
KR20210023846A (ko) 2021-03-04
US11679089B2 (en) 2023-06-20
MX2020013732A (es) 2021-02-26
CL2020003277A1 (es) 2021-07-09
WO2019246201A1 (en) 2019-12-26
MA52957A (fr) 2021-04-28
JP2021529735A (ja) 2021-11-04
IL279328A (en) 2021-01-31
CN112823018A (zh) 2021-05-18
AR115581A1 (es) 2021-02-03
AU2019288371A1 (en) 2020-12-03
SG11202011611XA (en) 2021-01-28
BR112020025831A2 (pt) 2021-03-23
US20190388374A1 (en) 2019-12-26
CA3099762A1 (en) 2019-12-26

Similar Documents

Publication Publication Date Title
JOP20200323A1 (ar) طرق لتصنيع تركيبات الأحماض الأمينية
PH12018501355A1 (en) Rsv f protein mutants
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
CY1124806T1 (el) Αντισωματα enanti-cd40 και χρησεις αυτων
PH12019501357A1 (en) Anti-ox40 antibodies and their uses
PH12020550051A1 (en) Glp-1 compositions and uses thereof
MX2020006612A (es) Compuesto que funciona como inhibidor de proteína de bromodominio y composición.
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
MY189454A (en) 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
WO2018081592A3 (en) Compositions and methods for the production of compounds
PH12018502714A1 (en) Nicotine particles and compositions
MX2020001885A (es) Formulaciones de daptomicina.
WO2020030984A3 (en) Compositions and methods for genome engineering with cas12a proteins
MX2022011973A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
MX2020008125A (es) Composiciones que comprenden berberina.
MY181478A (en) Mixed decyl mercaptans compositions and methods of making same
WO2018132821A3 (en) Elastomeric proteins